Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Assets Average (2022 - 2025)

Prime Medicine filings provide 4 years of Assets Average readings, the most recent being $363.9 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 15.46% to $363.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $363.9 million, a 15.46% increase, with the full-year FY2025 number at $320.1 million, up 30.3% from a year prior.
  • Assets Average hit $363.9 million in Q4 2025 for Prime Medicine, up from $332.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $363.9 million in Q4 2025 to a low of $216.5 million in Q4 2023.
  • Median Assets Average over the past 4 years was $298.9 million (2023), compared with a mean of $297.2 million.
  • The widest YoY moves for Assets Average: up 45.57% in 2024, down 25.4% in 2024.
  • Prime Medicine's Assets Average stood at $287.8 million in 2022, then decreased by 24.77% to $216.5 million in 2023, then surged by 45.57% to $315.1 million in 2024, then rose by 15.46% to $363.9 million in 2025.
  • The last three reported values for Assets Average were $363.9 million (Q4 2025), $332.0 million (Q3 2025), and $303.6 million (Q2 2025) per Business Quant data.